In a strategic move to strengthen healthcare innovation and expand access to quality services, PharmAccess Nigeria has announced the appointment of a distinguished Advisory Board. The board, comprising leading experts in healthcare policy, digital transformation, and investment, will support the organization’s mission of bridging healthcare equity gaps across Nigeria.
PharmAccess has been at the forefront of health system transformation for over a decade, implementing initiatives such as the Kwara Health Insurance Scheme, the SafeCare quality improvement methodology, and mobile tuberculosis screening applications. With the increasing adoption of digital and mobile technology, the Advisory Board will play a critical role in advancing sustainable healthcare innovation and strategic partnerships.
The Advisory Board includes esteemed members such as Dr. Wiebe Boer, the Chief Growth Officer at JIPA Network; Dr. Ebere Okereke, the Chief Program Officer at Reaching the Last Mile; and Dr. Olufemi Sunmonu, the Program Director for EQUIP in Northeast London and co-founder of PurpleSource Healthcare in Nigeria.
Dr. Wiebe Boer is a seasoned social entrepreneur and business leader with an impressive track record in philanthropy, sustainable development, and impact investment. He currently serves as the Chief Growth Officer at JIPA Network, a fast-growing healthcare company operating in South Florida and the Caribbean. Dr. Boer has held leadership roles at notable organizations, including the Rockefeller Foundation, the Tony Elumelu Foundation, and Shell’s All On investment fund. His vast experience in driving social impact initiatives and sustainable development will be invaluable in advancing PharmAccess’ mission.
Dr. Ebere Okereke on the other hand, is a distinguished global health expert and public health physician with over 30 years of experience in infectious disease control, pandemic preparedness, and health policy development. Dr. Okereke currently serves as the Chief Program Officer at Reaching the Last Mile, the philanthropic foundation of His Highness Sheikh Mohammed Bin Zayed, President of the UAE. She has previously held important positions at Public Health England, the Africa CDC, the Tony Blair Institute for Global Change, amongst others. Her expertise in shaping health policy and driving public health initiatives across the continent will contribute to PharmAccess’ efforts to enhance health system resilience and improve access to healthcare.
Lastly, Dr. Olufemi Sunmonu is a healthcare strategist with a focus on digital transformation and quality improvement. He serves as the Program Director for EQUIP in Northeast London, where he leads data-driven healthcare enhancements that impact over 2 million people. Dr. Sunmonu is also the co-founder of PurpleSource Healthcare in Nigeria, a network of tech-enabled primary care clinics aimed at improving healthcare delivery. His innovative work in digital healthcare solutions and his deep understanding of primary care will provide invaluable insights to PharmAccess as it continues to expand its impact in Nigeria.
Speaking on the appointment of the new Advisory Board, Mrs. Njide Ndili, Country Director of PharmAccess, highlighted the significance of this strategic development for the organization. She said, “The establishment of this Advisory Board marks a critical milestone in our efforts to scale transformative healthcare models across Nigeria. With their extensive expertise, we are poised to advance our initiatives in digital health, quality healthcare initiatives, value-based care models, and sustainable healthcare financing. Their guidance will be instrumental in strengthening our impact and accelerating the progress toward bridging healthcare equity gaps in the country.”
Adding to this, Nicole Spieker, Group Chief Executive Officer of PharmAccess, emphasized the organization’s commitment to driving healthcare transformation in Nigeria. She said: “PharmAccess is committed to driving transformational change in healthcare by unlocking the power of data and technology. To help accelerate our impact we are proud to announce the launch of our advisory board for Nigeria, and welcome our new advisory board members. Their expertise and leadership will be invaluable as we work to strengthen health systems and improve access to quality care across the country.”
The Advisory Board will provide strategic advice on market intelligence, sustainable financing mechanisms, and partnership opportunities, ensuring that PharmAccess stays at the forefront of digital health innovation and healthcare investments. The board’s guidance will help align PharmAccess’ initiatives with national and global health priorities, facilitating the adoption of impactful healthcare solutions.
PharmAccess remains committed to supporting government led initiatives to strengthen Nigeria’s healthcare system. With the support of the new Advisory Board, PharmAccess is poised to expand its impact and continue its mission to improve healthcare access for millions of Nigerians. PharmAccess Nigeria is part of the PharmAccess Group, a pan-African organization funded by the Ministry of Foreign Affairs of the Kingdom of the Netherlands.